ProAssurance Nears Completion of Merger with The Doctors Company
Claim 55% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
ProAssurance ( (PRA) ) has shared an announcement.
ProAssurance’s planned merger with The Doctors Company, first agreed on March 19, 2025, continued to advance in 2025 and 2026, with shareholders approving related proposals on June 24, 2025 and the U.S. Federal Trade Commission granting early termination of the Hart-Scott-Rodino waiting period on July 2, 2025. As of June 2, 2026, the parties had secured final approvals from insurance regulators in seven U.S. jurisdictions, as well as from Lloyd’s of London and the Cayman Islands Monetary Authority, leaving California’s review pending and the deal’s completion still contingent on remaining closing conditions.
The extensive regulatory progress signals that the combination is moving closer to completion and underscores the complexity of consolidating two major players in the medical and specialty insurance space. While the companies continue to expect closing by June 30, 2026, the uncertain timing of California’s review and other customary conditions introduce ongoing execution risk for shareholders, employees, and business partners during the merger’s final stages.
The most recent analyst rating on (PRA) stock is a Hold
with a $25.00 price target.
To see the full list of analyst forecasts on ProAssurance stock,
see the PRA Stock Forecast page.
Spark’s Take on PRA Stock
According to Spark, TipRanks’ AI Analyst, PRA is a Neutral.
The score is mainly constrained by weak cash-flow conversion and top-line/premium contraction signals despite an earnings rebound and a manageable balance sheet. Technicals are modestly supportive, but a high P/E without a dividend meaningfully reduces the valuation score.
To see Spark’s full report on PRA stock,
click here.
More about ProAssurance
ProAssurance is an insurance provider operating through multiple regulated subsidiaries and licensed entities, including interests at Lloyd’s of London and in the Cayman Islands. Its business is subject to oversight by insurance regulators across numerous U.S. states and international jurisdictions, reflecting a diversified footprint in specialized insurance markets.
Average Trading Volume: 902,464
Technical Sentiment Signal: Hold
Current Market Cap: $1.24B
For a thorough assessment of PRA stock, go to TipRanks’ Stock Analysis page.
